The United States Food and Drug Administration (FDA) has announced it will consider products outside the nanoscale, up to 1,000 nanometres (nm), to involve nanotechnology and so be potentially liable for “particular examination.”
At last week's Controlled Release Society annual meeting, an
industry analyst looked at nanotechnology and its increasingly
prominent role, but noted that much of what is touted as
nanotechnology actually falls outside the nano-scale.
Germany's Capsulution Nanoscience is tapping into Qiagen's
molecular diagnostics expertise in a collaboration that will
explore new diagnostic and therapeutic possibilities for cancer and
MFIC Corporation, which designs, manufactures and distributes
high-performance Microfluidizer materials-processing equipment for
the biotechnology, pharmaceutical, chemical, cosmetics/personal
care and food industries through its...
A transdermal patch for needle-free delivery of insulin and a
diagnostic test for rapid detection of meningococcal disease are
among the products under development by two new Australian
companies set up to commercialise the research...
US-based nanotech process provider MFIC has announced a 35 per cent
increase in revenue over the full-year 2006 to $15.7m (€12.1m),
driven by a rising demand from drugmakers for microfluidics
UK research organisations, biopharmaceutical and food
manufacturers, along with those in other industries are been asked
to voluntarily provide any information on nanotechnologies they are
working on, under a programme launched this...
A new report warns that as nanotechnology becomes a reality, Europe
must not miss the boat, and raises the alarm that the potential
benefits of nanomedicine in Europe will be lost without major
investment in R&D.
A newly signed research and collaboration agreement between MFIC
Corporation and The University of Massachusetts Lowell (UML) will
facilitate the development of new applications, processes and
products in the growing area of nanomaterials.
Nanogen has been issued with a European patent, which relates to a
nanofabrication technology combining a manufacturing platform and
nanostructures that is set to broaden Nanogen's position in the
nanotechnology and nanomanufacturing...
According to a new report, nanotechnology is set to play a major
part in drug delivery systems especially for tumour therapies. The
report cites nanoparticles as being particularly suited to curing
specific conditions such as cancer,...
The emergence of nanotechnology is likely to have a significant
impact on drug delivery sector, affecting just about every route of
administration from oral to injectable, according to specialist
market research firm NanoMarkets.
Japanese company GSI Creos has unveiled the first prototype of a
new cell culture reactor that uses nanotechnology to support the
growth of more cells than conventional reactors. The bioreactor
could potentially boost the yield of...
The top pharmaceutical companies are investing less money and
people in nanotechnology than other industries, despite pressure to
replace fading blockbuster drugs as fewer drugs come out of the
sector's R&D pipeline, according...
A new European project on the emerging discipline of
nanobiotechnology aims to tackle the thorny issue of safety as well
as develop new materials for drug delivery and other medical uses,
reports Phil Taylor.
The UK's Science and Innovation Minister, Lord Sainsbury, has
defended his government's record on nanotechnology, after last
week's report from the House of Commons science and technology
select committee blamed policy...
Leaving aside the safety concerns surrounding nanotechnology set
out in In-Pharmatechnologist.com's lead article today, a
report commissioned by the UK government has claimed that a lack of
foresight by both policy makers and...
Microfluidics has launched the first research-scale versions of its
patented High-Pressure Multiple Stream Mixer Reactor (MMR), claimed
to create uniform particles smaller than anything achieved using